PharmaTher Files The Psilocybin Psychedelic Combinations Therapies Patent With The FDA

PharmaTher is a specialty life science company focused on the research and development of psychedelics. They have recently filed patents with the FDA to mix FDA approved neurological drugs with Ketamine, Psilocybin, Cannabis, and MDMA to treat neurological disorders using GelMA micro-needle technology and transdermal patches.